Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Epstein-Barr virus infection	9/202	3.1362071703102256e-14	3.19893131371643e-12	367.2279792746114	-408.2556109234594	IFNA1;IKBKE;IKBKG;MAP3K14;NFKB1;NFKB2;RELB;TNF;TNFAIP3
KEGG_2021_Human	NF-kappa B signaling pathway	7/104	5.559862940056923e-12	1.8903533996193537e-10	191.7422680412371	-443.0178139513241	IKBKG;MAP3K14;NFKB1;NFKB2;RELB;TNF;TNFAIP3
KEGG_2021_Human	C-type lectin receptor signaling pathway	7/104	5.559862940056923e-12	1.8903533996193537e-10	191.7422680412371	-443.0178139513241	IKBKE;IKBKG;MAP3K14;NFKB1;NFKB2;RELB;TNF
KEGG_2021_Human	Osteoclast differentiation	6/127	2.676173433294478e-09	6.824242254900919e-08	98.51652892561984	-292.7975978962654	IKBKG;MAP3K14;NFKB1;NFKB2;RELB;TNF
KEGG_2021_Human	RIG-I-like receptor signaling pathway	5/70	1.0300956143193924e-08	2.1013950532115604e-07	123.12307692307692	-308.3116784019305	IFNA1;IKBKE;IKBKG;NFKB1;TNF
KEGG_2021_Human	NOD-like receptor signaling pathway	6/181	2.2716519598648245e-08	3.861808331770202e-07	67.65428571428572	-217.27332348682836	IFNA1;IKBKE;IKBKG;NFKB1;TNF;TNFAIP3
KEGG_2021_Human	IL-17 signaling pathway	5/94	4.613881700165173e-08	6.723084763097823e-07	89.65168539325843	-243.34942399375765	IKBKE;IKBKG;NFKB1;TNF;TNFAIP3
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	6/219	7.114581922498571e-08	8.715098919641791e-07	55.316901408450704	-183.6813524270677	IKBKG;MAP3K14;NFKB1;NFKB2;RELB;TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	5/104	7.689793164389816e-08	8.715098919641791e-07	80.4949494949495	-223.94034919826578	IFNA1;IKBKE;IKBKG;NFKB1;TNF
KEGG_2021_Human	TNF signaling pathway	5/112	1.1171098780714114e-07	1.1394520756328397e-06	74.40186915887851	-210.55667833010622	IKBKG;MAP3K14;NFKB1;TNF;TNFAIP3
KEGG_2021_Human	Measles	5/139	3.301250436176135e-07	3.061159495363325e-06	59.208955223880594	-175.30198917758304	IFNA1;IKBKE;IKBKG;NFKB1;TNFAIP3
KEGG_2021_Human	MAPK signaling pathway	6/294	4.1027904082915563e-07	3.487371847047823e-06	40.520833333333336	-140.03790468986205	IKBKG;MAP3K14;NFKB1;NFKB2;RELB;TNF
KEGG_2021_Human	Hepatitis C	5/157	6.062762738655014e-07	4.756936918021626e-06	52.078947368421055	-157.67845628585505	IFNA1;IKBKE;IKBKG;NFKB1;TNF
KEGG_2021_Human	Hepatitis B	5/162	7.08729574350555e-07	4.819361105583774e-06	50.388535031847134	-153.38399251928269	IFNA1;IKBKE;IKBKG;NFKB1;TNF
KEGG_2021_Human	Cytosolic DNA-sensing pathway	4/63	6.811887802918996e-07	4.819361105583774e-06	90.49717514124293	-200.30830604753126	IFNA1;IKBKE;IKBKG;NFKB1
KEGG_2021_Human	Influenza A	5/172	9.546833775920581e-07	6.0861065321493705e-06	47.31137724550898	-145.44295329077605	IFNA1;IKBKE;IKBKG;NFKB1;TNF
KEGG_2021_Human	Lipid and atherosclerosis	5/215	2.882246411730869e-06	1.7293478470385215e-05	37.41904761904762	-118.71127334987257	IFNA1;IKBKE;IKBKG;NFKB1;TNF
KEGG_2021_Human	Coronavirus disease	5/232	4.193632481505705e-06	2.3763917395198994e-05	34.541850220264315	-110.54645043588327	IFNA1;IKBKE;IKBKG;NFKB1;TNF
KEGG_2021_Human	T cell receptor signaling pathway	4/104	5.130876847568527e-06	2.7544707286946827e-05	53.12	-132.3420645012429	IKBKG;MAP3K14;NFKB1;TNF
KEGG_2021_Human	Apoptosis	4/142	1.7706963311466067e-05	9.030551288847694e-05	38.309178743961354	-100.74461672219032	IKBKG;MAP3K14;NFKB1;TNF
KEGG_2021_Human	Human papillomavirus infection	5/331	2.3833262795393072e-05	0.00011576156214905207	23.74846625766871	-77.98718048580317	IFNA1;IKBKE;IKBKG;NFKB1;TNF
KEGG_2021_Human	Legionellosis	3/57	3.859950954844004e-05	0.00017896136245185835	63.6031746031746	-112.5302356283168	NFKB1;NFKB2;TNF
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	4/193	5.926501543349045e-05	0.00026282745974852287	27.79188712522046	-75.84859252655446	IFNA1;IKBKE;IKBKG;NFKB1
KEGG_2021_Human	Adipocytokine signaling pathway	3/69	6.857856994284154e-05	0.00029145892225707656	51.96103896103896	-96.07609532933417	IKBKG;NFKB1;TNF
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	3/70	7.160249860764975e-05	0.000292138194319211	51.17910447761194	-94.92366080084827	IKBKG;MAP3K14;NFKB1
KEGG_2021_Human	Human immunodeficiency virus 1 infection	4/212	8.553680416035766e-05	0.00033556746247524933	25.192307692307693	-69.28980198257669	IFNA1;IKBKG;NFKB1;TNF
KEGG_2021_Human	Human cytomegalovirus infection	4/225	0.00010785574304042276	0.0004074550292638193	23.671191553544496	-65.36509727839072	IFNA1;IKBKG;NFKB1;TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	5/498	0.00016972194719545373	0.0006182728076405814	15.365111561866126	-50.06173980977876	IFNA1;IKBKE;IKBKG;NFKB1;TNF
KEGG_2021_Human	Chagas disease	3/102	0.00021994493140062025	0.0007735994138918367	34.497835497835496	-68.58379435140506	IKBKG;NFKB1;TNF
KEGG_2021_Human	Toxoplasmosis	3/112	0.00029005838446074546	0.0009861985071665344	31.293577981651374	-63.06696788213405	IKBKG;NFKB1;TNF
KEGG_2021_Human	Yersinia infection	3/137	0.0005248515914701949	0.0017269310429019317	25.375266524520256	-52.38188378130509	IKBKG;NFKB1;TNF
KEGG_2021_Human	Fluid shear stress and atherosclerosis	3/139	0.0005476317685268026	0.001745576262179183	24.99579831932773	-51.672386684351224	IKBKG;NFKB1;TNF
KEGG_2021_Human	Necroptosis	3/159	0.0008112107732862489	0.00250737875379386	21.736263736263737	-45.441996978119036	IFNA1;TNF;TNFAIP3
KEGG_2021_Human	Primary immunodeficiency	2/38	0.0009469209383415865	0.0028407628150247596	55.77777777777778	-62.87407127134141	AIRE;IKBKG
KEGG_2021_Human	Tuberculosis	3/180	0.0011634285381276748	0.003390563168257795	19.106537530266344	-40.222430877266724	IFNA1;NFKB1;TNF
KEGG_2021_Human	Pathogenic Escherichia coli infection	3/197	0.0015104299457678824	0.004279551513009	17.394698085419734	-36.72187076283526	IKBKG;NFKB1;TNF
KEGG_2021_Human	Viral carcinogenesis	3/203	0.0016469262374030193	0.004540175032840756	16.86	-35.61063787888018	IKBKG;NFKB1;NFKB2
KEGG_2021_Human	Pathways in cancer	4/531	0.0028173482711087343	0.007180891563710484	9.539531941808981	-25.060320343159585	IFNA1;IKBKG;NFKB1;NFKB2
KEGG_2021_Human	Shigellosis	3/246	0.002856466854245349	0.007180891563710484	13.800705467372135	-29.076248648200146	IKBKG;NFKB1;TNF
KEGG_2021_Human	Acute myeloid leukemia	2/67	0.002921615714870147	0.007180891563710484	30.78076923076923	-39.02900444511024	IKBKG;NFKB1
KEGG_2021_Human	Inflammatory bowel disease	2/65	0.002752148243719554	0.007180891563710484	31.765873015873016	-40.07734547796954	NFKB1;TNF
KEGG_2021_Human	Salmonella infection	3/249	0.0029568377027043165	0.007180891563710484	13.627177700348431	-28.69609856443984	IKBKG;NFKB1;TNF
KEGG_2021_Human	Pancreatic cancer	2/76	0.0037436519554145367	0.008485611098939617	27.006756756756758	-34.90410589940028	IKBKG;NFKB1
KEGG_2021_Human	Pertussis	2/76	0.0037436519554145367	0.008485611098939617	27.006756756756758	-34.90410589940028	NFKB1;TNF
KEGG_2021_Human	Chronic myeloid leukemia	2/76	0.0037436519554145367	0.008485611098939617	27.006756756756758	-34.90410589940028	IKBKG;NFKB1
KEGG_2021_Human	Leishmaniasis	2/77	0.0038409427449733026	0.00851687304320167	26.643333333333334	-34.49723066158141	NFKB1;TNF
KEGG_2021_Human	B cell receptor signaling pathway	2/81	0.004241897027183041	0.00920581908026958	25.281645569620252	-32.95657984925952	IKBKG;NFKB1
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.005099890907028776	0.01083726817743615	22.933908045977013	-30.23706529396038	IKBKG;NFKB1
KEGG_2021_Human	Small cell lung cancer	2/92	0.005440715912052039	0.01109906046058616	22.16111111111111	-29.32328202848766	IKBKG;NFKB1
KEGG_2021_Human	Th1 and Th2 cell differentiation	2/92	0.005440715912052039	0.01109906046058616	22.16111111111111	-29.32328202848766	IKBKG;NFKB1
KEGG_2021_Human	Prostate cancer	2/97	0.006031622120792857	0.012063244241585714	20.981578947368423	-27.909669646620806	IKBKG;NFKB1
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.01255341111444739	20.331632653061224	-27.120602948412195	NFKB1;TNF
KEGG_2021_Human	Amoebiasis	2/102	0.006650847322673755	0.012799743904013642	19.92	-26.61700675496218	NFKB1;TNF
KEGG_2021_Human	Th17 cell differentiation	2/107	0.00729809140286639	0.013780897709223035	18.95952380952381	-25.42995427691617	IKBKG;NFKB1
KEGG_2021_Human	Insulin resistance	2/108	0.007430876215757518	0.013780897709223035	18.778301886792452	-25.204052222837845	NFKB1;TNF
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.007955391465782094	0.014490177312674529	9.422466422466423	-19.140881053489387	IFNA1;IKBKG;NFKB1
KEGG_2021_Human	Sphingolipid signaling pathway	2/119	0.008964014539605185	0.016040868123504012	16.98931623931624	-22.939511285821055	NFKB1;TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	2/131	0.010785539693571716	0.01896767325421233	15.385658914728682	-20.853034219946885	IFNA1;TNF
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.025723753516744267	12.933006535947712	-17.54750234216727	NFKB1;TNF
KEGG_2021_Human	Chemokine signaling pathway	2/192	0.0223068963273402	0.037921723756478336	10.365789473684211	-13.920708621090329	IKBKG;NFKB1
KEGG_2021_Human	Ras signaling pathway	2/232	0.03174764714886429	0.05308622965875669	8.519565217391305	-11.194266119915625	IKBKG;NFKB1
KEGG_2021_Human	Chemical carcinogenesis	2/239	0.03354092254711208	0.05518022741621665	8.26054852320675	-10.803362590978235	IKBKE;NFKB1
KEGG_2021_Human	Asthma	1/31	0.03774052193970927	0.06110370218810072	29.77037037037037	-16.126223630092912	TNF
KEGG_2021_Human	African trypanosomiasis	1/37	0.04489527895199197	0.0715518508297372	24.790123456790123	-13.876145105511855	TNF
KEGG_2021_Human	Allograft rejection	1/38	0.046083072411820386	0.07231497516931815	24.117117117117118	-13.560364723090352	TNF
KEGG_2021_Human	Cytokine-cytokine receptor interaction	2/295	0.04928069612200721	0.07616107582492022	6.6339590443686	-8.300944532041967	IFNA1;TNF
KEGG_2021_Human	Graft-versus-host disease	1/42	0.05082096328161841	0.07736922768246385	21.75338753387534	-12.4264883862275	TNF
KEGG_2021_Human	Type I diabetes mellitus	1/43	0.052002121863896134	0.0780031827958442	21.232804232804234	-12.171283962486152	TNF
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.08209915664307878	19.809876543209878	-11.46289716991079	TNF
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.08435122542250716	18.962174940898347	-11.032973182262484	MAP3K14
KEGG_2021_Human	Cocaine addiction	1/49	0.05906133610748362	0.08484868004173703	18.564814814814813	-10.829316375605623	NFKB1
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.08533045337921379	18.183673469387756	-10.63265628196324	TNF
KEGG_2021_Human	Autoimmune thyroid disease	1/53	0.06374115884515756	0.08906298907131605	17.128205128205128	-10.081098986019231	IFNA1
KEGG_2021_Human	Alzheimer disease	2/369	0.07347088540357372	0.10127067988060161	5.2459128065395095	-6.1057863985118	NFKB1;TNF
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.11030213992697921	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.08339759626885078	0.11192835288714183	12.880837359098228	-7.74542097629872	NFKB1
KEGG_2021_Human	Antigen processing and presentation	1/78	0.09251851170984433	0.12255698953771588	11.531024531024531	-6.958150954500108	TNF
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.13867655608671922	9.961298377028713	-6.010407578745034	TNF
KEGG_2021_Human	Rheumatoid arthritis	1/93	0.1094003568916107	0.14090751457965048	9.632850241545894	-5.8073541800756905	TNF
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.14090751457965048	9.528076463560334	-5.7422174156532195	TNF
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.14126740773813143	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Pathways of neurodegeneration	2/475	0.11356791602477233	0.14126740773813143	4.014270613107822	-4.131104230952899	NFKB1;TNF
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.14229168050386992	8.94388327721661	-5.375723879218761	TNF
KEGG_2021_Human	Hematopoietic cell lineage	1/99	0.11607356788707196	0.14229168050386992	9.036281179138323	-5.434068642481248	TNF
KEGG_2021_Human	Longevity regulating pathway	1/102	0.11939326812281527	0.14327192174737832	8.764576457645765	-5.262086311101535	NFKB1
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.1507413413987906	8.189300411522634	-4.893732148578802	NFKB1
KEGG_2021_Human	Neurotrophin signaling pathway	1/119	0.13799386385009413	0.16178590934148968	7.4858757062146895	-4.435243302362896	NFKB1
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.1487694756391342	0.17243734676354192	6.892361111111111	-4.041189892105298	NFKB1
KEGG_2021_Human	Systemic lupus erythematosus	1/135	0.15517650047822218	0.1778427308851535	6.5787728026534	-3.830244937455702	TNF
KEGG_2021_Human	Ubiquitin mediated proteolysis	1/140	0.16048249753809815	0.18188016387651124	6.338129496402877	-3.6670604531534	AIRE
KEGG_2021_Human	Breast cancer	1/147	0.16786050842791683	0.18815133911700566	6.0289193302891935	-3.455697502915966	NFKB2
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.1942214275941946	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.19441502252796763	5.672401433691756	-3.209640069203435	NFKB1
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.19908921959039574	5.456866804692892	-3.0596637281364782	IFNA1
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.2264575140589247	4.657210401891253	-2.4954112144854435	NFKB1
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.2272831873296531	4.5823152995927865	-2.441961042053517	NFKB1
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.23604021421937818	4.283224400871459	-2.2275706216550177	TNF
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.22481613944093093	0.23604021421937818	4.326732673267327	-2.2588473265567357	NFKB1
KEGG_2021_Human	cAMP signaling pathway	1/216	0.23752539179620868	0.24472313094154835	4.058397932816537	-2.065502377074288	NFKB1
KEGG_2021_Human	Prion disease	1/273	0.2910658516731848	0.2968871687066485	3.184640522875817	-1.4307154955453085	TNF
KEGG_2021_Human	MicroRNAs in cancer	1/310	0.3239838755949599	0.32719163673946444	2.7900035958288387	-1.143955577607994	NFKB1
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3695602254440061	2.3584328129782675	-0.8341701676241932	TNF
